How e-cigarette prevention messages affect teenagers
Impact of e-cigarette prevention messages on adolescents
This study is looking at how talking to teenagers aged 12 to 20 in a way that really connects with them can help stop them from using e-cigarettes, and it aims to create messages that will encourage them to stay away from vaping.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10840952 on NIH RePORTER |
What this research studies
This research investigates how effective communication can prevent e-cigarette use among adolescents aged 12 to 20. The study aims to identify and develop impactful prevention messages by engaging with teenagers through focus groups and expert consultations. By understanding adolescents' responses to various message themes, the research seeks to create tailored communication strategies that resonate with young people and discourage vaping. The ultimate goal is to strengthen their commitment to avoid e-cigarettes and reduce nicotine addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who are at risk of using e-cigarettes or are currently using them.
Not a fit: Patients who are not adolescents or who do not engage with e-cigarettes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies that help adolescents avoid e-cigarette use and its associated health risks.
How similar studies have performed: Previous research has shown that effective communication strategies can significantly influence health behaviors among adolescents, suggesting potential success for this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Noar, Seth Michael — Univ of North Carolina Chapel Hill
- Study coordinator: Noar, Seth Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.